Frontlight ResearchEarly access
Lung cancer trials in United States
900 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Assess Intravenous ABBV-1480 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First Line Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer in Adult Participants
- Where
- Fort Wayne
- Age
- 18 years and over
- People
- 940 worldwide
- Run by
- AbbVie
See details and how to joinNCT07756645 · EU 2026-526573-42-00 - Phase 1/2Taking peopleGI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
- Where
- Huntersville, New York
- Age
- 18 years and over
- People
- 317 worldwide
- Run by
- GI Innovation, Inc.
See details and how to joinNCT04977453 - No phaseTaking peopleBiology of Young Lung Cancer Study: The YOUNG LUNG Study
- Where
- Boston
- Age
- 15 years and over
- People
- 500
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT05265429 - Phase 1/2Taking peopleStudy of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
- Where
- Billings, Boston, Cleveland, Detroit, Duarte, Fairfax, Gilbert, Grand Island, Houston, Irvine, Irving, Los Angeles, Memphis, Nashville, New York, Pittsburgh, Plantation, Sacramento, Saint Augustine, San Diego, San Francisco, Seattle, Stanford, Tampa, Vallejo, Washington D.C., Westbury
- Age
- 18 years and over
- People
- 616 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06162221 · EU 2025-521147-21-00 - Phase 1/2Taking peopleA Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
- Where
- Boston, Detroit, Dyer, Fairfax, Fairway, Houston, Kingwood, La Jolla, Lake Mary, Orange, Philadelphia, San Antonio, San Francisco, West Valley City
- Age
- 18 years and over
- People
- 293 worldwide
- Run by
- Frontier Medicines Corporation
See details and how to joinNCT06244771 - Phase 2Taking peopleRadiation Prior to TKI to Delay Progression in Advanced Driver-Mutated Non-small Cell Lung Cancers (RadiaNCe Lung X)
- Where
- Milwaukee
- Age
- 18 years and over
- People
- 34
- Run by
- Medical College of Wisconsin
See details and how to joinNCT06305715 - Phase 2Taking peopleTrial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC
- Where
- Birmingham, Charleston, Derby, Durham, Guilford, Los Angeles, Mineola, New Haven, New York, North Haven, Tampa, Trumbull, Waterbury
- Age
- 18 years and over
- People
- 107 worldwide
- Run by
- CatalYm GmbH
See details and how to joinNCT07098988 · EU 2024-516792-32-01 - Phase 1/2Taking peopleA Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy
- Where
- Houston, Lexington, Seattle
- Age
- 18 years and over
- People
- 80 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07564401 - Phase 1Taking peopleA PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab
- Where
- Duarte
- Age
- 18 years and over
- People
- 6
- Run by
- City of Hope Medical Center
See details and how to joinNCT07619599 - No phaseTaking peopleCollection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
- Where
- Bethesda
- Age
- 3 years and over
- People
- 1,100
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT01441089 - No phaseTaking peopleTissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
- Where
- Bethesda
- Age
- 18 years and over
- People
- 2,000
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT02146170 - No phaseEnrolling by invitationProspective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
- Where
- Bethesda
- Age
- 18 years and over
- People
- 1,200
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05600933 - Phase 1Taking peopleStudy of Aerosolized Antibiotics and Pembrolizumab in Advanced Non-small Cell Lung Cancer
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 23
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05777603 - Phase 1Taking peopleA Study of ZL-1310 in Subjects With Small Cell Lung Cancer
- Where
- Buffalo, Charleston, Cleveland, Detroit, Duarte, Durham, Fairfax, Hackensack, New Haven, Pittsburgh, Sarasota
- Age
- 18 years and over
- People
- 339 worldwide
- Run by
- Zai Lab (Shanghai) Co., Ltd.
See details and how to joinNCT06179069 - Phase 2Taking peopleTOP 2301: Neoadjuvant Chemo for NSCLC
- Where
- Durham
- Age
- 18 years and over
- People
- 63
- Run by
- Duke University
See details and how to joinNCT06385262 - Phase 2Taking peopleA Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)
- Where
- Baltimore, Fargo, Lexington, Philadelphia, Sioux Falls
- Age
- 18 years and over
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06731907 · EU 2024-515772-12-00 - Phase 2Taking peopleFucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer
- Where
- Scottsdale
- Age
- 18 years and over
- People
- 34
- Run by
- Mayo Clinic
See details and how to joinNCT06855524 - Phase 1/2Taking peopleAVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Where
- Atlanta, Boston, Dallas, Denver, Fairfax, Gilbert, Houston, Los Angeles, New Haven, New York, Orlando, Philadelphia, San Antonio, Sarasota, Seattle, Tampa, Washington D.C., West Valley City
- Age
- 18 years to 75 years
- People
- 480 worldwide
- Run by
- Avenzo Therapeutics, Inc.
See details and how to joinNCT07038343 - Phase 3Taking peopleA Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
- Where
- Akron, Aurora, Austin, Bethesda, Broomall, Clermont, Cleveland, Columbia, Dallas, Detroit, Fairfax, Iowa City, La Jolla, Louisville, Mayfield Heights, Media, Nashville, New Haven, Odessa, Orange City, Peoria, Pittsburgh, Rockledge, Sacramento, Sarasota, Silver Spring, St Louis, Stony Brook, St. Petersburg, Tampa, The Bronx, Waukee, West Palm Beach
- Age
- 18 years and over
- People
- 480 worldwide
- Run by
- Zai Lab (Shanghai) Co., Ltd.
See details and how to joinNCT07218146 - Phase 2Taking peopleImmunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
- Where
- Corona, Duarte, Goodyear, Huntington Beach, Irvine, Lancaster, Long Beach, Newnan, Newport Beach, South Pasadena, Torrance, Upland, Zion
- Age
- 18 years and over
- People
- 535
- Run by
- City of Hope Medical Center
See details and how to joinNCT07288034 - Phase 1Taking peopleA First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
- Where
- Dallas, Hackensack, Houston, Nashville, New York, Seattle, St Louis
- Age
- 18 years and over
- People
- 110
- Run by
- Moonlight Bio, Inc
See details and how to joinNCT07488923 - Phase 1Taking peopleA Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid Tumors
- Where
- Grand Rapids, Huntersville, Irving
- Age
- 18 years and over
- People
- 130
- Run by
- AbbVie
See details and how to joinNCT07807956 · EU 2026-526097-17-00 - No phaseTaking peopleEvaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
- Where
- Bethesda
- Age
- 2 years to 120 years
- People
- 1,559
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT00242723 - Phase 1/2Taking peopleDose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Where
- Boston, Denver, Houston, Miami, Nashville, San Antonio
- Age
- 18 years and over
- People
- 330
- Run by
- ModeX Therapeutics, An OPKO Health Company
See details and how to joinNCT06239194 - Phase 1/2Taking peopleSMP-3124LP in Adults With Advanced Solid Tumors
- Where
- Celebration, Chicago, Columbus, Denver, Houston, Los Angeles, Nashville, San Francisco, Seattle
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT06526819